A Phase I Trial Evaluating the Addition of Lenalidomide to Patients with Relapsed/Refractory Multiple Myeloma Progressing on Ruxolitinib and Methylprednisolone
Article in Targeted Oncology (April 2024)
The most recent citing publications are shown below. View all 16 publications that cite this research output on Dimensions.
Article in Targeted Oncology (April 2024)
Article in Oncotarget (February 2024)
Article in British Journal of Haematology (December 2022)